Abstract
Get full access to this article
View all access options for this article.
References
1.
Sasinowski
FJ
. Quantum of effectiveness evidence in FDA’s approval of orphan drugs: cataloguing FDA’s flexibility in regulating therapies for persons with rare disorders . Drug Information Journal . 2012 ;46 (2 ):238 -263 .
2.US Food and Drug Administration . FDA rare disease patient advocacy day , 2012 . http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm294868.htm. Accessed March 21, 2012 .
3.US Food and Drug Administration . Search orphan drug designations and approvals Web site . http://www.accessdata.fda.gov/scripts/opdlisting/oopd/. Accessed March 22, 2012 .
4.US Food and Drug Administration . Drugs@FDA . http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed March 22, 2012 .